U.S. IPO Weekly Recap: August Kicks Off With Flurry Of Biotech IPOs

This week saw 6 IPOs and 5 SPACs priced, while 2 IPOs and 8 SPACs submitted filings. Looking ahead, a sizable US IPO is scheduled for the coming week alongside a notable closed-end fund. Overall, the update is broadly neutral with limited immediate market-wide impact.

Analysis

This week saw 6 IPOs and 5 SPACs priced, while 2 IPOs and 8 SPACs submitted filings. Looking ahead, a sizable US IPO is scheduled for the coming week alongside a notable closed-end fund. Overall, the update is broadly neutral with limited immediate market-wide impact.